CORRESP Filing
Axe Compute Inc.
Date: Nov. 21, 2025 · CIK: 0001446159 · Accession: 0001171843-25-007491
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291021
Letter
Re: Predictive Oncology Inc.
November 21, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Attn: Lauren Nguyen, Office Chief Juan Grana, Staff Attorney
Registration Statement on Form S-3 Filed October 22, 2025 File No. 333-291021 Acceleration Request Requested Date: November 25, 2025 Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Predictive Oncology Inc. (the " Registrant ") hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-291021) (the " Registration Statement ") be declared effective at the "Requested Date" and "Requested Time" set forth above, or as soon as practicable thereafter.
We request that we be notified of the effectiveness of the Registration Statement by telephone to Era Anagnosti of DLA Piper LLP (US) at (202) 799-4087. Thank you for your assistance.
Very truly yours,
Predictive Oncology Inc.
Show Raw Text
CORRESP 1 filename1.htm November 21, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attn: Lauren Nguyen, Office Chief Juan Grana, Staff Attorney Re: Predictive Oncology Inc. Registration Statement on Form S-3 Filed October 22, 2025 File No. 333-291021 Acceleration Request Requested Date: November 25, 2025 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Predictive Oncology Inc. (the " Registrant ") hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-291021) (the " Registration Statement ") be declared effective at the "Requested Date" and "Requested Time" set forth above, or as soon as practicable thereafter. We request that we be notified of the effectiveness of the Registration Statement by telephone to Era Anagnosti of DLA Piper LLP (US) at (202) 799-4087. Thank you for your assistance. Very truly yours, Predictive Oncology Inc. /s/ Josh Blacher Josh Blacher Chief Financial Officer cc: Raymond Vennare (Chief Executive Officer, Predictive Oncology Inc.) Sara Turken (General Counsel, Predictive Oncology Inc.) Era Anagnosti (DLA Piper LLP (US))